Related Experiment Video

Updated: Dec 13, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.2K

PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy

Fabiana Conciatori1, Chiara Bazzichetto1, Italia Falcone1

  • 1Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

International Journal of Molecular Sciences
|July 31, 2020
PubMed

Insights

Rewiring the immune system shows promise in cancer treatment. This review explores how the tumor suppressor phosphatase and tensin homolog (PTEN) influences the tumor microenvironment and immunotherapy response, highlighting its role as a potential biomarker.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Cancer immunotherapy aims to re-engineer the host immune system towards an anti-tumor state, showing significant clinical efficacy in various cancers.
  • Despite advancements, many immunotherapies face clinical failure, often attributed to a lack of reliable prognostic and predictive biomarkers.
  • The tumor suppressor gene, phosphatase and tensin homolog on chromosome 10 (PTEN), is increasingly recognized for its role in modulating the tumor microenvironment (TME) and influencing immunotherapy outcomes.

Purpose of the Study:

  • To review the current understanding of PTEN's diverse functions within different tumor microenvironment compartments.
  • To elucidate how PTEN influences immune and stromal cells, thereby affecting sensitivity or resistance to immunotherapy.
  • To discuss the potential of PTEN as a biomarker for predicting clinical response to cancer immunotherapy.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of PTEN's role in immune cell function within the TME.
  • Examination of PTEN's impact on stromal cell components of the TME.
  • Synthesis of data on PTEN's modulation of resistance and sensitivity to various immunotherapies.

Main Results:

  • PTEN plays a critical role in shaping the TME, impacting both immune and stromal cell populations.
  • Altered PTEN status influences the efficacy of different immunotherapeutic strategies.
  • PTEN's function within the TME is a key determinant of patient response to immunotherapy.

Conclusions:

  • PTEN is a crucial regulator of the tumor microenvironment and immunotherapy response.
  • Understanding PTEN's multifaceted roles is essential for developing more effective cancer immunotherapies.
  • PTEN holds significant potential as a predictive biomarker for cancer immunotherapy outcomes.
Keywords:
PTENcancerimmune cellsimmunoevasionimmunotherapy

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.5K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.9K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K